Synapse - Lindsey Roeker

Results (146)

Pirtobrutinib in post-cBTKi CLL/SLL: ∼30 months follow-up and subgroup analysis with/without prior BCL2i from the phase 1/2 BRUIN study

Meeting Abstract

Woyach, J. A.; Brown, J. R.; Ghia, P.; Roeker, L. E.; Patel, K.; Eyre, T. A.; Munir, T.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; more...
Blood (2023)

Fulltext@MSK | Save

Outcomes of patients with richter transformation without prior chemoimmunotherapy for CLL/SLL: An international multicenter retrospective study

Meeting Abstract

Kittai, A. S.; Huang, Y.; Miller, S.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E. A.; more...
Blood (2023)

Fulltext@MSK | Save

Pirtobrutinib in richter transformation: Updated efficacy and safety results with 18-month median survival follow-up from the phase 1/2 BRUIN study

Meeting Abstract

Wierda, W. G.; Shah, N. N.; Cheah, C. Y.; Lewis, D.; Hoffmann, M. S.; Coombs, C. C.; Lamanna, N.; Ma, S.; Jagadeesh, D.; Munir, T.; more...
Blood (2023)

Fulltext@MSK | Save

Treatment effectiveness with venetoclax-based therapy after Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: An international real-world study

Meeting Abstract

Ghosh, N.; Lamanna, N.; Eyre, T. A.; Coombs, C. C.; Manzoor, B. S.; Brown, J. R.; Tuncer, H. H.; Ujjani, C. S.; Leslie, L. A.; Roeker, L. E.; more...
Blood (2023)

Fulltext@MSK | Save

Genomic evolution and resistance during pirtobrutinib therapy in covalent btk-inhibitor (cBTKi) pre-treated chronic lymphocytic leukemia patients: Updated analysis from the BRUIN study

Meeting Abstract

Brown, J. R.; Desikan, S. P.; Nguyen, B.; Won, H.; Tantawy, S. I.; McNeely, S.; Marella, N.; Ebata, K.; Woyach, J. A.; Patel, K.; more...
Blood (2023)

Fulltext@MSK | Save

Despite high rates of remission, treatment of IDH-mutant AML with hypomethylating agents and venetoclax is associated with frequent treatment delays, modifications, and transfusions

Meeting Abstract

Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G.; Borge, P.; Berman, E.; Geyer, M. B.; Goldberg, A. D.; Haque, T.; Rampal, R. K.; more...
Blood (2023)

Fulltext@MSK | Save

Comparing acalabrutinib and ibrutinib in the real world: A study of 2,509 patients with chronic lymphocytic leukemia

Meeting Abstract

Christofyllakis, K.; Roeker, L.; DerSarkissian, M.; Ryan, K. J.; Chen, Y.; Wahlstrom, S. K.; Hakre, S.; Yu, L.; Guo, H.; Mato, A. R.
Oncology Research and Treatment (2023)

Fulltext@MSK | Save

Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients